Cigenta

Medicinal product

(Invented) name

Cigenta

Active substance (s)

Natrio citratas

Strength

136 mmol/l

Pharmaceutical form

infuzinis tirpalas

Route (s) of administration

naudoti ne kūne

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B05ZB, Hemofiltrates

Marketing authorisation holder

Fresenius Medical Care Deutschland GmbH, Vokietija

Date of authorisation

2021-12-30

Date of renewal

Documents

4870 Pakuotės lapelis 2023 10 23.docx

4870 Cigenta RPP 2023 10 23.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

DE/H/6388/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

1000 ml tirpalo sudėtis:	1000 ml
Natrio citratas dihidratas	136 mmol/l

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
107796	93901	1093901	maišelis	1500 ml, N8 (SecuNect jungties sistema)		Receptinis	LT/1/21/4870/001	Netiekiama	-	-	No	-	-	Download
107797	93902	1093902	maišelis	1500 ml, N8 (Safe●Lock jungties sistema)		Receptinis	LT/1/21/4870/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2021-12-30	Registruotas